AVITA Medical, Inc. (NASDAQ:RCEL) Q2 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the AVITA Medical Second Quarter 2025 Earnings Conference Call.
Avita Medical Inc. (RCEL)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Opaleye Management James A. Silverman | 389,519 | $2,060,556 | -12% | 0.42% |
| 2. | Millennium Management Israel Englander | 369,192 | $1,953,026 | +2981% | 0% |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 76,825 | $406,405 | -33% | 0% |
| 4. | D E Shaw D. E. Shaw | 61,971 | $327,827 | -14% | 0% |
| 5. | Citadel Investment Group Ken Griffin | 58,761 | $310,846 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.52 | 2,000 | $9,040.00 | 31,657 | 2025-08-26 | Filing | |
| $5.00 | 10,000 | $50,000.00 | 76,771 | 2025-08-19 | Filing | |
| $4.81 | 2,000 | $9,620.00 | 29,657 | 2025-08-12 | Filing | |
| $8.30 | 11,000 | $91,300.00 | 56,749 | 2025-03-06 | Filing | |
| $10.09 | 10,000 | $100,900.00 | 45,749 | 2025-02-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.29 | 1,445 | $19,204.05 | 11,580 | 2023-12-26 | Filing | |
| $12.49 | 2,500 | $31,225.00 | 20,614 | 2023-12-21 | Filing | |
| $12.27 | 2,518 | $30,895.86 | 20,596 | 2023-12-13 | Filing | |
| $15.84 | 4,193 | $66,417.12 | 42,257 | 2023-08-21 | Filing | |
| $7.18 | 150,000 | $1,077,000.00 | 229,543 | 2022-11-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,895,655 | $10,028,016 | 0% | |
| 2. | 1,450,367 | $7,672,441 | 0% | |
| 3. | 618,342 | $3,271,706 | 0% | |
| 4. | 528,784 | $2,797,267 | 0% | |
| 5. | 409,799 | $2,167,837 | 0% |
News See All
AVITA Medical, Inc. (NASDAQ:RCEL) Q1 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to AVITA Medical First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.
AVITA Medical, Inc. (RCEL): A Bull Case Theory
We came across a bullish thesis on AVITA Medical, Inc. (RCEL) on Substack by Steve Wagner. In this article, we will summarize the bulls’ thesis on RCEL. AVITA Medical, Inc.
AVITA Medical, Inc. (NASDAQ:RCEL) Q4 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the AVITA Medical Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
AVITA Medical, Inc. (RCEL): A Bull Case Theory
We came across a bullish thesis on AVITA Medical, Inc. (NASDAQ:RCEL) on Substack by Steve Wagner. In this article, we will summarize the bulls’ thesis on RCEL. AVITA Medical, Inc.
11 Best Cosmetic Surgery and Aesthetics Stocks to Invest in Now
In the face of economic uncertainty, consumer preferences in the beauty industry are changing.
AVITA Medical, Inc. (RCEL): A Bull Case Theory
We came across a bullish thesis on AVITA Medical, Inc. (RCEL) on Substack by Steve Wagner. In this article, we will summarize the bulls’ thesis on RCEL. AVITA Medical, Inc.
AVITA Medical, Inc. (NASDAQ:RCEL) Q3 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the AVITA Medical, Inc. Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
AVITA Medical Inc (NASDAQ:RCEL) A Bull Case Theory
We came across a bullish thesis on AVITA Medical Inc (RCEL) on ValueInvestorsClub by FT42. In this article we will summarize the bulls' thesis on RCEL.
AVITA Medical, Inc. (NASDAQ:RCEL) Q2 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the AVITA Medical Second Quarter Conference Call. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
